Regarding, Willins, and Wallner, IJROBP 39:347-353; 1997.
作者信息
Vikram B
出版信息
Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):1008-9.
PMID:9531390
Abstract
摘要
相似文献
1
Regarding, Willins, and Wallner, IJROBP 39:347-353; 1997.关于威林斯、和瓦尔纳，《国际放射肿瘤学、生物学、物理学杂志》第39卷：第347 - 353页；1997年。
Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):1008-9.
2
Patients who have had permanent implant prostate brachytherapy.接受过永久性植入前列腺近距离放射治疗的患者。
Radiother Oncol. 2006 Sep;80(3):395. doi: 10.1016/j.radonc.2006.06.016. Epub 2006 Aug 24.
3
Regarding, Kubo, Coursey, Hanson et al., IJROBP 1998; 40:697-702.关于久保、考西、汉森等人，《国际放射肿瘤学、生物学、物理学杂志》1998年；40:697 - 702。
Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):469-70.
4
A method for implementing the American Association of Physicists in Medicine Task Group-43 dosimetry recommendations for 125I transperineal prostate seed implants on commercial treatment planning systems: regarding Luse et al. IJROBP 37:737-741; 1997.一种在商业治疗计划系统上实施美国医学物理学家协会任务组43关于¹²⁵I经会阴前列腺籽源植入剂量学建议的方法：参考卢斯等人，《国际放射肿瘤学、生物学、物理学杂志》37:737 - 741；1997年。
Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):243.
5
Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma.间质内碘-125放疗联合辅助治疗临床局限性前列腺癌。
Cancer. 1998 Jan 1;82(1):229-30. doi: 10.1002/(sici)1097-0142(19980101)82:1<230::aid-cncr32>3.0.co;2-1.
6
Prostate brachytherapy as monotherapy: Are there gaps, holes, and islands in the argument? In regard to Wallner et al. (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).前列腺近距离放射治疗作为单一疗法：该论点中是否存在漏洞、缺陷和空白？关于瓦尔纳等人（《国际放射肿瘤学、生物学、物理学杂志》2003年；57:1297 - 1303）的研究。
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):305; author reply 305-6. doi: 10.1016/j.ijrobp.2004.03.041.
7
[Interstitial radiotherapy of prostatic carcinoma with 125-iodine. Radiation protection measures].[125碘前列腺癌间质放疗。辐射防护措施]
Strahlentherapie Sonderb. 1978;75:213-6.
8
Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):962; author reply 962-3. doi: 10.1016/j.ijrobp.2008.02.039.
9
Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology. 2000 Jun;215 Suppl:1383-400.
10
In regards to Wallner et al: (125)I versus (103)PD for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):319; author reply 319-20. doi: 10.1016/j.ijrobp.2004.01.010.
Zotero 插件